Bovine leukemia virus, a distinguished member of the human T-lymphotropic virus family. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Bovine leukemia virus, a distinguished member of the human T-lymphotropic virus family.

Princess Takamatsu Symp. 1984;15:219-27. Unique Identifier : AIDSLINE MED/86111563
Burny A; Bruck C; Cleuter Y; Couez D; Deschamps J; Ghysdael J; Gregroire D; Kettmann R; Mammerickx M; Marbaix G; et al

Abstract: Bovine leukemia virus (BLV) has many structural and functional characteristics in common with the human T-lymphotropic viruses (HTLVs). The most striking feature of these retroviruses is the existence of a long open reading frame (LOR) located at the 3' side of the provirus between the right end of the 3' side of env gene and the left end of the long terminal repeat (LTR). It is believed that the LOR protein product is of critical importance in the induction process of the tumor phase of bovine leukemia. Prevention of BLV infection will be attempted by vaccination. To that aim, careful study of BLV envelope glycoprotein epitopes has shown that epitopes F, G, and H play a major role in biological activities of the virus. Their native structure depends upon glycosylation of the peptide backbone.
Keywords: Animal Cattle Cattle Diseases/IMMUNOLOGY DNA, Viral/ANALYSIS Genes, Viral HTLV-BLV Viruses/IMMUNOLOGY Leukemia/*ETIOLOGY/IMMUNOLOGY/VETERINARY Leukemia Virus, Bovine/GENETICS/IMMUNOLOGY/*PATHOGENICITY Retroviridae/*PATHOGENICITY Support, Non-U.S. Gov't JOURNAL ARTICLE REVIEW

KWDanimalcattlecattlediseases/immunologydna,viral/analysisgenes,viralhtlv-blvviruses/immunologyleukemia/KWDetiology/immunology/veterinaryleukemiavirus,bovine/genetics/immunology/KWDpathogenicityretroviridae/KWDpathogenicitysupport,non-uKWDsKWDgov'tjournalarticlereview
860530
M8650230

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .